Theriva Biologics, Inc.

TOVX · AMEX
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$4-$13-$4-$4
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0-$0-$0
Stock-Based Comp.$0$0$0$0
Change in WC-$1-$1-$0-$1
Other Non-Cash$1$9$0$0
Operating Cash Flow-$4-$5-$5-$5
Investing Activities
PP&E Inv.-$0-$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$0-$0$0$0
Financing Activities
Debt Repay.$0$0$1$0
Stock Issued$0$7$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$0$0$2$0
Financing Cash Flow-$0$7$3$0
Forex Effect-$0$0$0-$0
Net Chg. in Cash-$5$2-$2-$5
Supplemental Information
Beg. Cash$12$10$12$17
End Cash$8$12$10$12
Free Cash Flow-$4-$5-$5-$5